TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2407885

Group type: EXPERIMENTAL
Intervention: Cuprophan (CU) dialyzer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hemophan (HE) dialyzer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polysulfone F6 (PS) dialyzer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dialyzers sterilized with ETO
Number of subjects: 0

Group type: COMPARATOR
Intervention: C3a and C5a
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flow cytofluorometry and immunohistochemical methods (APAAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C8 dependent generation of PGE2 and TNF alpha by adherent monocytes induced by cuprophan
Number of subjects: 0
Study: 6985702

Group type: EXPERIMENTAL
Intervention: Delta-9-tetrahydrocannabinol (THC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Prochlorperazine (compazine)
Number of subjects: 25
Study: 30726946

Group type: EXPERIMENTAL
Intervention: High dietary insulin load
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: High dietary insulin index
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: High dietary insulin load in patients with obesity
Number of subjects: 1023
Study: 28320345

Group type: EXPERIMENTAL
Intervention: Telephone follow-up at 8, 30, and 60 days after treatment for attempted suicide
Number of subjects: 436

Group type: COMPARATOR
Intervention: No telephone follow-up (Control group)
Number of subjects: 436
Study: 25555539

Group type: EXPERIMENTAL
Intervention: Positive behavior support (PBS)
Number of subjects: 731

Group type: COMPARATOR
Intervention: Dietary quality of meals
Number of subjects: 731
Study: 25000151

Group type: EXPERIMENTAL
Intervention: Labisia pumila var alata water extract (400 mg)
Number of subjects: 197
Study: 23251355

Group type: EXPERIMENTAL
Intervention: Web-based tailored lifestyle advice and face-to-face counselling
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 340
Study: 19300199

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal over 3 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (continued steroids)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 17562632

Group type: EXPERIMENTAL
Intervention: Support group (n = 14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 29
Study: 15156427

Group type: EXPERIMENTAL
Intervention: Directly Administered Antiretroviral Therapy (DAART) program, 1 of 2 daily HAART doses, 5 days per week for 6 months
Number of subjects: 67
Study: 11472883

Group type: EXPERIMENTAL
Intervention: Levodopa (one 250/50‐mg tablet)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Biperiden (one 3‐mg tablet)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Levodopa and Biperiden
Number of subjects: 38
Study: 9505256

Group type: EXPERIMENTAL
Intervention: Residual limb
Number of subjects: 16

Group type: COMPARATOR
Intervention: Contralateral limb
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Age-dependent factors
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Deep pressure sensation
Number of subjects: 16
Study: 8001212

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg per dose, two doses)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Omeprazole (two doses)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Omeprazole (single dose on the morning of surgery)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Omeprazole-Omeprazole and Omeprazole-Placebo Groups
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo-Placebo and Placebo-Omeprazole Groups
Number of subjects: 104
Study: 2123152

Group type: EXPERIMENTAL
Intervention: rt-PA (0.6 mg/kg, 2-minute infusion)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 363702

Group type: EXPERIMENTAL
Intervention: Oral rapid neuroleptization method (maximum 80 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fixed standard dosage (20 mg/day)
Number of subjects: 32
Study: 31447409

Group type: EXPERIMENTAL
Intervention: 40 μg teriparatide + denosumab 60 mg every 6 months
Number of subjects: 76

Group type: COMPARATOR
Intervention: 20 μg teriparatide + denosumab 60 mg every 6 months
Number of subjects: 76
Study: 27299475

Group type: EXPERIMENTAL
Intervention: memantine
Number of subjects: 30

Group type: COMPARATOR
Intervention: risperidone
Number of subjects: 30
Study: 26992609

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 717

Group type: EXPERIMENTAL
Intervention: Interleukin (IL)-6
Number of subjects: 717

Group type: EXPERIMENTAL
Intervention: Baseline CRP concentration
Number of subjects: 717

Group type: EXPERIMENTAL
Intervention: Baseline IL-6 levels
Number of subjects: 717

Group type: EXPERIMENTAL
Intervention: Change in biomarker levels during the first month after DVT
Number of subjects: 717
Study: 23917905

Group type: EXPERIMENTAL
Intervention: Ultrasound monitoring with audio reminders and written individual feedback
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (manual observations)
Number of subjects: 106
Study: 21325465

Group type: EXPERIMENTAL
Intervention: 16 mg phytoestrogens
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 mg phytoestrogens
Number of subjects: 60
Study: 19264792

Group type: EXPERIMENTAL
Intervention: CoPAT (Outpatient parenteral antimicrobial therapy)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard therapy (semi‐synthetic penicillin or vancomycin with initial low‐dose gentamicin)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CoPAT with daptomycin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CoPAT with standard therapy
Number of subjects: 200
Study: 17091660

Group type: EXPERIMENTAL
Intervention: Fuji VII sealant material
Number of subjects: 200

Group type: COMPARATOR
Intervention: Concise resin-based sealant
Number of subjects: 200
Study: 16429657

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg per day for 4 weeks before operation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 12726782

Group type: EXPERIMENTAL
Intervention: 12-session group-based exercise intervention for smoking cessation; Exercise instructions began at Session 8 and continued through Session 12
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 12-session group-based exercise intervention for smoking cessation; Exercise commenced at Session 1
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Combined subjects from both studies
Number of subjects: 91
Study: 9893087

Group type: EXPERIMENTAL
Intervention: Written materials only
Number of subjects: 1247

Group type: COMPARATOR
Intervention: Written materials and educational videotape
Number of subjects: 1247
Study: 7579025

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 671
Study: 1968319

Group type: EXPERIMENTAL
Intervention: 20 mg dipotassium chlorazepate (DC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6992913

Group type: EXPERIMENTAL
Intervention: Plain catgut subcutaneous fat stitch
Number of subjects: 208

Group type: COMPARATOR
Intervention: No fat suture
Number of subjects: 208
Study: 12381252

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg daily
Number of subjects: 9014
Study: 29908043

Group type: EXPERIMENTAL
Intervention: PF-06741086 (30 mg subcutaneously to 440 mg intravenously)
Number of subjects: 41
Study: 26893507

Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standardized exercises
Number of subjects: 100

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 100
Study: 25307141

Group type: EXPERIMENTAL
Intervention: Pre-WTG exercise training for participants
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nonparticipant controls
Number of subjects: 19
Study: 22087803

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 30
Study: 19657665

Group type: EXPERIMENTAL
Intervention: Cyst aspiration (n = 90)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No-intervention (n = 90)
Number of subjects: 180
Study: 18045719

Group type: EXPERIMENTAL
Intervention: Goat milk-derived E2 antigen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16134998

Group type: EXPERIMENTAL
Intervention: Hypobaric environment (2500 m)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normobaric environment (200 m)
Number of subjects: 20
Study: 11856987

Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticosteroids
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 10023789

Group type: EXPERIMENTAL
Intervention: Breathe Right (BR) strip
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Xylometazoline
Number of subjects: 54

Group type: COMPARATOR
Intervention: Nasal baseline maneuver
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Nasal maneuver after application of xylometazoline
Number of subjects: 54
Study: 7775644

Group type: EXPERIMENTAL
Intervention: 5 mg/day finasteride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2157231

Group type: EXPERIMENTAL
Intervention: Gepirone 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gepirone 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gepirone (both dosages)
Number of subjects: 12
Study: 6765467

Group type: EXPERIMENTAL
Intervention: Indomethacin 0.2 mg/kg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 30913943

Group type: EXPERIMENTAL
Intervention: TENS combined with traditional physical therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Traditional physical therapy (Control)
Number of subjects: 29
Study: 28321022

Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg twice-daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel (150 mg once-daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 26156114

Group type: EXPERIMENTAL
Intervention: 1 Hz stimulation of the sensory vagal area at the left ear for 4 h/day during 3 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: 25 Hz stimulation of the sensory vagal area at the left ear for 4 h/day during 3 months
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups (1 Hz and 25 Hz)
Number of subjects: 46
Study: 23303149

Group type: EXPERIMENTAL
Intervention: Pursestring closure
Number of subjects: 61

Group type: COMPARATOR
Intervention: Linear closure (Control)
Number of subjects: 61
Study: 21134027

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (CRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: RV outflow tract pacing
Number of subjects: 40
Study: 19548930

Group type: EXPERIMENTAL
Intervention: Zurich protocol (n = 3 teeth/5 roots)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Eastman Dental Institute (EDI) protocol (n = 4 teeth/4 roots)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All microscopy techniques (SEM, LM, TEM) used on each root
Number of subjects: 9
Study: 16842379

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus paclitaxel
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 160
Study: 14636938

Group type: EXPERIMENTAL
Intervention: Manual vacuum aspiration (MVA)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Manual vacuum aspiration (MVA) with contraceptive counseling
Number of subjects: 154

Group type: COMPARATOR
Intervention: Sharp curettage
Number of subjects: 154
Study: 11038410

Group type: EXPERIMENTAL
Intervention: 5.5% CHO solution (8 ml (kg body mass (BM))‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo solution (CON trial)
Number of subjects: 7
Study: 8860111

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg, three times a day for 3 days)
Number of subjects: 20
Study: 2051556

Group type: EXPERIMENTAL
Intervention: Face mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ventilated canopy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mouthpiece/nose clip
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All systems
Number of subjects: 30
Study: 6686774

Group type: EXPERIMENTAL
Intervention: beta-pyridylcarbinol (Ronicol 300)
Number of subjects: 10
Study: 31445316

Group type: EXPERIMENTAL
Intervention: ω-3 supplementation (2.5 g/d for 45 days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ω-3 supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (olive oil capsules)
Number of subjects: 40
Study: 29168358

Group type: EXPERIMENTAL
Intervention: Combined multi-strain and multi-species probiotics (Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus plantorum, Bifidobacterium animalis) with prebiotics (fructooligosaccharides and galactooligosaccharides)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Combined multi-strain and multi-species probiotics
Number of subjects: 110
Study: 24939630

Group type: EXPERIMENTAL
Intervention: Trans-cervical double balloon catheter with extra-amniotic saline infusion (EASI)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Trans-cervical double balloon catheter without extra-amniotic saline infusion (Control)
Number of subjects: 160
Study: 24101043

Group type: EXPERIMENTAL
Intervention: Cabazitaxel plus prednisone (C + P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mitoxantrone plus prednisone (C)
Number of subjects: 0
Study: 21767400

Group type: EXPERIMENTAL
Intervention: Alternate Day Fasting (ADF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calorie Restriction (CR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 19499762

Group type: EXPERIMENTAL
Intervention: Preventive protocol (PG) including preoperative upper limb lymphscintigraphy (LS), principles for lymphedema risk minimization, and early management of identified lymphedema.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 55
Study: 16719655

Group type: EXPERIMENTAL
Intervention: Memory for bound combinations of features (colors or shapes) with simultaneous presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory for bound combinations of features (colors or shapes) with sequential presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory for feature combinations under demanding concurrent verbal tasks
Number of subjects: 0
Study: 15305887

Group type: EXPERIMENTAL
Intervention: gliclazide MR 30-120 mg daily
Number of subjects: 845

Group type: COMPARATOR
Intervention: glimepiride 1-6 mg daily
Number of subjects: 845
Study: 11778352

Group type: EXPERIMENTAL
Intervention: Regular physical activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive affect
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative affect
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older, married, and employed women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Women perceiving high risk for breast cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More educated women and those with higher perceived risk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Married women
Number of subjects: 0
Study: 10806834

Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 7976452

Group type: EXPERIMENTAL
Intervention: Fear of AIDS
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fear of other somatic illness
Number of subjects: 28

Group type: COMPARATOR
Intervention: Other suicides (control group)
Number of subjects: 28
Study: 2722050

Group type: EXPERIMENTAL
Intervention: Extraperitoneal selective paraaortic lymphadenectomy (EP-SPAL)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Transperitoneal selective paraaortic lymphadenectomy (TP-SPAL)
Number of subjects: 284
Study: 31322915

Group type: EXPERIMENTAL
Intervention: Pelvic side wall boost (dose not specified)
Number of subjects: 285

Group type: COMPARATOR
Intervention: No pelvic side wall boost
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Dose escalated combined external beam with interstitial boost
Number of subjects: 285
Study: 29231608

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia combined with EA pretreatment at Zusanli (ST 36), Shangjuxu (ST 37), Xiajuxu (ST 39), Tianshu (ST 25) and Zhongwan (CV 12)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Total intravenous anesthesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia combined with EA pretreatment at Zusanli (ST 36), Shangjuxu (ST 37), Xiajuxu (ST 39)
Number of subjects: 60
Study: 26156691

Group type: EXPERIMENTAL
Intervention: B-mode ultrasound-guided percutaneous transhepatic gallbladder drainage (PTGD) + laparoscopic cholecystectomy (LC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC) alone
Number of subjects: 35
Study: 23305460

Group type: EXPERIMENTAL
Intervention: 25 IU/kg of 4-factor prothrombin complex concentrate (PCC)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 40 IU/kg of 4-factor prothrombin complex concentrate (PCC)
Number of subjects: 59
Study: 21467200

Group type: EXPERIMENTAL
Intervention: Reduced needle (RN) with a diameter of 0.9 mm for the last 50 mm from the tip
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard needle (SN) with a diameter of 1.4 mm
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Reduced needle (RN)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard needle (SN)
Number of subjects: 257
Study: 18279411

Group type: EXPERIMENTAL
Intervention: Intermittent physiotherapy (4 times a week for 4 weeks with a 6-week treatment pause, total of 30 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Continuous physiotherapy (once or twice a week for a total of 30 weeks)
Number of subjects: 25
Study: 16413647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New treatments for OCD
Number of subjects: 0
Study: 11914892

Group type: EXPERIMENTAL
Intervention: Technetium-99m ciprofloxacin scan
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Late imaging assessment
Number of subjects: 71

Group type: COMPARATOR
Intervention: Articular uptake
Number of subjects: 71
Study: 10591286

Group type: EXPERIMENTAL
Intervention: 10 mg ecopipam
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 25 mg ecopipam
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 100 mg ecopipam
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9002920

Group type: EXPERIMENTAL
Intervention: Chlorhexidine swabbing (10 mL 0.12% chlorhexidine gluconate)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Chlorhexidine swabbing (10 mL 0.12% chlorhexidine gluconate) with dental prophylaxis
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Chlorhexidine swabbing at maintenance frequency with periodic dental prophylaxis
Number of subjects: 44

Group type: COMPARATOR
Intervention: Chlorhexidine swabbing
Number of subjects: 44
Study: 2248068

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 30
Study: 6101960

Group type: COMPARATOR
Intervention: pemoline (20 and 40 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: prolintane hydrochloride (5 and 10 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: methylphenidate hydrochloride (10 and 20 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: fencamfamine hydrochloride (10 and 20 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: caffeine anhydrous (100, 200 and 300 mg)
Number of subjects: 6
Study: 6462734

Group type: EXPERIMENTAL
Intervention: Low dose nitrofurantoin
Number of subjects: 0
Study: 31182699

Group type: EXPERIMENTAL
Intervention: Transanal Hemorrhoidal Dearterialization (THD)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Milligan Morgan Hemorrhoidectomy (MM)
Number of subjects: 87
Study: 30426700

Group type: EXPERIMENTAL
Intervention: Warm condition (26°C-27°C)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control condition (19°C-20°C)
Number of subjects: 25
Study: 25921050

Group type: EXPERIMENTAL
Intervention: PR-fampridine
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 25227824

Group type: EXPERIMENTAL
Intervention: Educational intervention based on protection motivation theory and implementation intentions
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 200
Study: 22691567

Group type: EXPERIMENTAL
Intervention: Citicoline (1000 mg every 12 h intravenously during the first 3 days and orally thereafter for a total of 6 weeks [2×500 mg oral tablets given every 12 h])
Number of subjects: 2298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2298
Study: 19837639

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 99

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 99
Study: 17588546

Group type: EXPERIMENTAL
Intervention: Serotonergic + Noradrenergic antidepressant drugs (e.g., venlafaxine, duloxetine, milnacipran, mirtazapine, mianserin, moclobemide)
Number of subjects: 17036

Group type: COMPARATOR
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 17036

Group type: EXPERIMENTAL
Intervention: Serotonergic + Noradrenergic antidepressant drugs
Number of subjects: 17036

Group type: COMPARATOR
Intervention: SSRIs
Number of subjects: 17036
Study: 16224163

Group type: EXPERIMENTAL
Intervention: Wavefront-guided LASIK
Number of subjects: 57
Study: 12063642

Group type: EXPERIMENTAL
Intervention: Valsartan (80 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10088764

Group type: EXPERIMENTAL
Intervention: Filtration leukocytapheresis (LCP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham apheresis (control group)
Number of subjects: 25